Nathalie Fretault
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Cancer-related Molecular Pathways, Viral gastroenteritis research and epidemiology
Most-Cited Works
- → PI3K inhibitors as new cancer therapeutics: implications for clinical trial design(2016)230 cited
- → Comparison of racecadotril and loperamide in children with acute diarrhoea(1999)91 cited
- → Challenges in the clinical development of PI3K inhibitors(2013)42 cited
- → Comparison of racecadotril and loperamide in adults with acute diarrhoea(1999)42 cited
- → Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial(2021)31 cited
- → Some Practical Considerations for Phase III Studies With Biomarker Evaluations(2014)7 cited
- → HIV-related diarrhea : Efficacy of acetorphan in a randomized controlled trial(1995)5 cited
- → Overcoming Phosphatidylinositol 3-Kinase (PI3K) Activation in Breast Cancer: Emerging PI3K Inhibitors(2015)4 cited
- → Case study using RWD in the context of a pivotal trial for regulatory approval in a rare disease(2023)3 cited
- → Double-blind study of the efficacy and safety of acetorphan versus loperamide in the treatment of acute diarrhea in adults(1995)2 cited